RCEL R&D Expenses
Avita Medical Inc · R&D Expenses
RCEL R&D Expenses
Latest reported$20.15Mperiod ending
RCEL TTM R&D Expenses ($2.53M → $20.15M)
TTM R&D Expenses
High-resolution chart · PNG
RCEL r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 20,145,000 | |
| 20,184,000 | |
| 20,839,000 | |
| 19,999,000 | |
| 21,679,000 | |
| 21,449,000 | |
| 20,359,000 | |
| 22,274,000 | |
| 21,240,000 | |
| 21,429,000 | |
| 20,821,000 | |
| 17,435,000 | |
| 16,840,000 | |
| 14,823,000 | |
| 13,857,000 | |
| 14,676,000 | |
| 14,265,000 | |
| 15,180,000 | |
| 15,669,000 | |
| 14,832,000 | |
| 14,818,000 | |
| 12,679,000 | |
| 12,678,558 | |
| 12,600,168 | |
| 12,823,500 | |
| 13,212,378 | |
| 11,108,213 | |
| 11,053,099 | |
| 10,995,873 | |
| 9,146,528 | |
| 10,919,031 | |
| 10,256,767 | |
| 9,242,477 | |
| 10,751,697 | |
| 8,851,080 | |
| 7,546,103 | |
| 6,277,993 | |
| 5,347,220 | |
| 4,429,239 | |
| 3,942,386 | |
| 3,458,140 | |
| 3,933,181 | |
| 4,390,572 | |
| 4,066,724 | |
| 3,765,239 | |
| 3,130,756 | |
| 2,507,248 | |
| 2,313,307 | |
| 2,124,733 | |
| 2,043,204 | |
| 1,968,078 | |
| 2,297,676 | |
| 2,572,947 | |
| 2,226,880 | |
| 2,529,128 |